Annie Fritsch

Annie Fritsch

Auto-generated profile, based on publicly available information

Annie Fritsch

Department of Plastic and Reconstructive Surgery, Rush University Medical Center , Chicago, IL

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
AHAaron N. Hendizadeh
Aaron N. Hendizadeh
NSNicholas Schmitz
Nicholas Schmitz
AFAnnie Fritsch
Annie Fritsch
LMLauren Martin
Lauren Martin
JPJaime Pardo Palau
Jaime Pardo Palau
GKGeorge Kokosis
George Kokosis

19 August 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
AFAnnie M. Fritsch
Annie M. Fritsch
BABrandon Alba
Brandon Alba
KHKelly A. Harmon
Kelly A. Harmon
ETEmma Theisen
Emma Theisen
GKGeorge Kokosis
George Kokosis

3 October 2026 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
SGSevasti Panagiota Glynou
Sevasti Panagiota Glynou
AFAnnie Fritsch
Annie Fritsch
FBFedra Britvic
Fedra Britvic
DGDimple K Gajjar
Dimple K Gajjar
RKRebecca Knackstedt
Rebecca Knackstedt
GKGeorge Kokosis
George Kokosis
Background: Postoperative physical therapy (PT) is well established after mastectomy to reduce upper-limb dysfunction, pain, and quality-of-life impairment. However, its role following breast reconstruction remains less clearly defined, largely due to concerns regarding reconstruction-specific complications. Objectives: To evaluate the effects of PT on functional shoulder range of motion (ROM), pain, upper-limb function, and quality of life (QoL) after breast reconstruction. Methods: A systematic review was conducted in accordance with PRISMA 2020 guidelines and registered with PROSPERO (CRD420251025047). PubMed/MEDLINE, Embase, Scopus, CINAHL, and CENTRAL were searched from inception to July 2025. Eligible studies included adults undergoing implant-based or autologous reconstruction receiving preoperative or postoperative PT interventions. Quality was assessed via RoB 2 and ROBINS-I. Due to heterogeneity, a narrative synthesis was conducted. Results: Fifteen studies (n = 1,020) were included. Early and structured physiotherapy consistently improved short-term shoulder ROM, upper-limb function, and quality-of-life outcomes without increasing surgical complications. Initiating rehabilitation within two weeks postoperatively accelerated flexion and abduction recovery compared with traditional four-week immobilization protocols. Functional outcomes varied by reconstruction type, suggesting differing rehabilitation needs following implant-based versus autologous procedures. Massage-based interventions showed limited additional benefit from adjunctive therapies such as acupuncture or meditation. Evidence regarding optimal intervention type, delivery mode, and long-term benefit was limited by heterogeneity and variable study quality. Conclusions: Postoperative PT is probably associated with earlier functional recovery and does not appear to compromise surgical safety, although certainty in this evidence is low across outcomes. However, the current evidence base is limited. High-quality, powered randomized controlled trials with standardized measures and longer follow-up are necessary to establish definitive clinical guidelines.

20 May 2026 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
NRNikki Rezania
Nikki Rezania
KHKelly A Harmon
Kelly A Harmon
OLOkensama La-Anyane
Okensama La-Anyane
AFAnnie Fritsch
Annie Fritsch
HJHelen Jeon
Helen Jeon
GKGeorge Kokosis
George Kokosis
Background: The SPY Fluorescence Imaging system enables intraoperative visualization of microvascular perfusion. Recently, SPY has been integrated with Quantitative Perfusion (QP) software to provide numerical assessment of relative tissue perfusion; however, clinically actionable perfusion thresholds predictive of mastectomy skin necrosis complications have not been clearly established. Objectives: The aim of this study was to evaluate the predictive performance of proposed SPY Portable Handheld Imaging Quantitative Perfusion (PHI QP) perfusion thresholds in patients undergoing staged breast reconstruction and to explore a QP-specific cutoff while accounting for nitroglycerin ointment use as a potential confounder. Methods: Patients undergoing staged breast reconstruction with tissue expander placement were included. SPY-PHI QP was used intraoperatively to assess relative perfusion. Diagnostic performance metrics—including sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and odds ratios—were calculated. A subanalysis excluding patients who received nitroglycerin ointment was performed to identify a QP-specific cutoff in unmanipulated tissue. Results: Fifty-eight patients (83 breasts) were included. Using a 33% perfusion threshold, SPY-PHI QP demonstrated high sensitivity (87.5%) and negative predictive value (98.3%) for mastectomy skin flap necrosis. After adjusting for nitroglycerin use, the association between low perfusion and mastectomy skin flap necrosis was attenuated. In patients who did not receive nitroglycerin, a perfusion threshold of 30% demonstrated optimal diagnostic performance (sensitivity 100%, specificity 76.7%, area under the curve 0.8875). Conclusions: SPY-PHI QP provides quantitative, real-time assessment of tissue perfusion during breast reconstruction. In patients not treated with nitroglycerin, a 30% perfusion threshold may be predictive of wound complications. These findings support further investigation of QP-specific thresholds in larger, prospective studies that account for adjunctive interventions. Level of Evidence: 4 (Therapeutic): For image description, please refer to the figure legend and surrounding text.